David Digomann

6PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 26, 2026
TIGIT+ CD4+ T Cell Enrichment in Colorectal Liver Metastases Is Associated with Shorter Survival.

|Nov 06, 2025
Intratumoral regulatory T cells are associated with treatment response to neoadjuvant chemotherapy and prognosis in gastroesophageal adenocarcinoma.

Franziska Baenke, Antonia Stammberger, Ulrich Sommer

|Oct 14, 2023
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer.

David Digomann, Max Heiduk, Charlotte Reiche

|May 16, 2023
VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer.

David Digomann, Johannes Strack, Max Heiduk

|May 04, 2023
TIGIT Expression Delineates T-cell Populations with Distinct Functional and Prognostic Impact in Pancreatic Cancer.

Max Heiduk, Anna Klimova, Charlotte Reiche

|Jul 06, 2019
SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.

David Digomann, Annett Linge, Anna Dubrovska

Pageof 1

Frequent Collaborators

5 joint publications

Adrian M Seifert

4 joint publications

Lena Seifert

2 joint publications

Max Heiduk

2 joint publications

Daniela E Aust